ACSL4 and neoplasm: It was shown that inhibition of ferroptosis by ectopically expressing GPX4 or silencing the expression of ACSL4 can reduce necrosis by 47% or 58–68%, respectively, and prolong the survival of tumor-bearing mice (Yee et al, 2020).